IRD Stock Analysis: Buy, Sell, or Hold?

IRD - Opus Genetics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$4.23
0.05 (1.20%) ▲
5d: +13.71%
30d: +6.02%
90d: -9.81%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026

Get Alerted When IRD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IRD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IRD is currently trading at $4.23, which is considered slightly low relative to its 30-day fair value range of $3.90 to $4.31.

Technical Outlook: Technically, IRD is in a strong uptrend. Immediate support is located at $3.88, while resistance sits at $4.67.

Market Sentiment: IRD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.56 (+149.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $3.90 - $4.31
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 94.7%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 149.5% below Wall St target ($10.56)

Trading Range Analysis

30-Day Trading Range $3.90 - $4.31
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $3.88
Resistance Level $4.68
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -5.54
Wall Street Target $10.56 (+149.5%)
Revenue Growth (YoY) -50.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 11:40 PM ET
Data refreshes hourly during market hours. Next update: 12:40 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ashwath Jayagopal SELL 3719 shares 2026-03-16
George Magrath SELL 24438 shares 2026-03-16
Joseph K Schachle SELL 3719 shares 2026-03-16

Unlock Insider Activity

See real-time buying/selling by company executives for IRD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 51 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$276 55 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$291 63 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
IMVT
Immunovant Inc
STRONG BUY
14 analysts
$46 61 BUY

More Analysis for IRD

IRD Technical Chart IRD Price Prediction IRD Earnings Date IRD Investment Advisor IRD Fair Price Analyzer IRD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals